ATE481406T1 - Pyrrolochinoxalinonderivate als antibakterielle mittel - Google Patents
Pyrrolochinoxalinonderivate als antibakterielle mittelInfo
- Publication number
- ATE481406T1 ATE481406T1 AT07727528T AT07727528T ATE481406T1 AT E481406 T1 ATE481406 T1 AT E481406T1 AT 07727528 T AT07727528 T AT 07727528T AT 07727528 T AT07727528 T AT 07727528T AT E481406 T1 ATE481406 T1 AT E481406T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrroloquinoxalinone
- derivatives
- antibacterial agents
- antibacterial
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0606970A GB0606970D0 (en) | 2006-04-06 | 2006-04-06 | Compounds |
GB0706023A GB0706023D0 (en) | 2007-03-26 | 2007-03-26 | Compounds |
PCT/EP2007/053056 WO2007115947A1 (en) | 2006-04-06 | 2007-03-29 | Pyrrolo-quinoxalinone derivatives as antibacterials |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE481406T1 true ATE481406T1 (de) | 2010-10-15 |
Family
ID=38580721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07727528T ATE481406T1 (de) | 2006-04-06 | 2007-03-29 | Pyrrolochinoxalinonderivate als antibakterielle mittel |
Country Status (9)
Country | Link |
---|---|
US (1) | US7709483B2 (de) |
EP (1) | EP2001887B1 (de) |
JP (1) | JP2009532423A (de) |
AR (1) | AR060287A1 (de) |
AT (1) | ATE481406T1 (de) |
DE (1) | DE602007009205D1 (de) |
PE (1) | PE20080182A1 (de) |
TW (1) | TW200815450A (de) |
WO (1) | WO2007115947A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1954697T3 (da) * | 2005-10-21 | 2010-06-14 | Glaxo Group Ltd | Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler |
EP1963324B1 (de) | 2005-12-22 | 2010-04-21 | Glaxo Group Limited | Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel |
GB0608263D0 (en) | 2006-04-26 | 2006-06-07 | Glaxo Group Ltd | Compounds |
GB0613208D0 (en) * | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
AU2008240764C1 (en) * | 2007-04-20 | 2011-10-20 | Glaxo Group Limited | Tricyclic nitrogen containing compounds as antibacterial agents |
BRPI0820394A2 (pt) * | 2007-11-26 | 2015-05-19 | Toyama Chemical Co Ltd | Composto, método para produzir um composto, derivado do ácido kójico, e, agente antibacteriano. |
EP2080761A1 (de) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Verbindungen |
MX2010008922A (es) | 2008-02-20 | 2010-09-07 | Actelion Pharmaceuticals Ltd | Compuestos antibioticos azatriciclicos. |
JP5474941B2 (ja) * | 2008-05-23 | 2014-04-16 | グラクソ グループ リミテッド | 窒素含有三環式化合物およびその抗菌剤としての使用 |
JP2011520944A (ja) * | 2008-05-23 | 2011-07-21 | グラクソ グループ リミテッド | 窒素含有三環式化合物および抗菌剤としてのその使用 |
AR073774A1 (es) | 2008-10-07 | 2010-12-01 | Actelion Pharmaceuticals Ltd | Compuestos antibioticos oxazolidinona triciclicos |
US20110275661A1 (en) | 2008-10-17 | 2011-11-10 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
JP4955835B2 (ja) | 2008-12-12 | 2012-06-20 | アクテリオン ファーマシューティカルズ リミテッド | 5−アミノ−2−(1−ヒドロキシ−エチル)−テトラヒドロピラン誘導体 |
US8318940B2 (en) | 2009-01-15 | 2012-11-27 | Glaxo Group Limited | Naphthyridin-2 (1 H)-one compounds useful as antibacterials |
CN101870653B (zh) * | 2009-04-23 | 2013-07-10 | 上海合全药业有限公司 | 一种2-甲基-3-氟-6-硝基苯甲酸的合成方法 |
MX2017002321A (es) | 2014-08-22 | 2017-08-02 | Glaxosmithkline Ip Dev Ltd | Compuestos que contienen nitrogeno triciclico para tratar infeccion por neisseria gonorrhoeae. |
EP3713941B1 (de) | 2017-11-24 | 2022-06-22 | Janssen Pharmaceutica NV | Pyrazolopyridinonverbindungen |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4603199A (en) * | 1982-10-25 | 1986-07-29 | Riker Laboratories, Inc. | Phenyl-substituted tricyclic antibacterial agent intermediates |
JPS6084287A (ja) * | 1983-10-14 | 1985-05-13 | Nissan Chem Ind Ltd | キノキザリノン誘導体,その製造法および農園芸用殺菌剤 |
FR2798656B1 (fr) | 1999-09-17 | 2004-12-17 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
AU2001241332A1 (en) | 2000-07-21 | 2002-02-05 | Michail Michailovich Budjonnuj | Plate for a stand-up meal |
KR20030019621A (ko) | 2000-07-26 | 2003-03-06 | 스미스클라인비이참피이엘시이 | 항균 활성을 갖는 아미노피페리딘 퀴놀린 및 그의아자이소스테릭 유사체 |
FR2816618B1 (fr) | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent |
GB0031088D0 (en) | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
WO2002050036A1 (en) | 2000-12-21 | 2002-06-27 | Ciba Speciality Chemicals Holding Inc. | Crystalline forms of cerivastatin sodium |
GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0118238D0 (en) | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
JP4508650B2 (ja) | 2002-01-29 | 2010-07-21 | グラクソ グループ リミテッド | アミノピペリジン化合物、当該化合物の製法および当該化合物を含有する医薬組成物 |
AR038240A1 (es) | 2002-01-29 | 2005-01-05 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion |
TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
AR040336A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
GB0217294D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicaments |
FR2844268B1 (fr) | 2002-09-11 | 2004-10-22 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent |
FR2844270B1 (fr) | 2002-09-11 | 2006-05-19 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent |
US7223776B2 (en) | 2002-10-10 | 2007-05-29 | Morphochem Ag | Compounds with anti-bacterial activity |
JP4704755B2 (ja) | 2002-11-05 | 2011-06-22 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 抗菌剤 |
ATE479683T1 (de) | 2002-11-05 | 2010-09-15 | Glaxo Group Ltd | Antibakterielle mittel |
AR042486A1 (es) | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion . |
TW200507841A (en) | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
FR2852954B1 (fr) | 2003-03-28 | 2006-07-14 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
DE10316081A1 (de) | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
WO2004104000A1 (ja) | 2003-05-23 | 2004-12-02 | Japan Tobacco Inc. | トリサイクリック縮合環化合物およびその医薬用途 |
FR2858619B1 (fr) | 2003-08-08 | 2006-12-22 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
FR2867472B1 (fr) | 2004-03-12 | 2008-07-18 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
US7691850B2 (en) | 2004-06-15 | 2010-04-06 | Glaxo Group Limited | Antibacterial agents |
FR2872164B1 (fr) | 2004-06-29 | 2006-11-17 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
EP1773831A1 (de) * | 2004-07-08 | 2007-04-18 | Glaxo Group Limited | Antibakterielle mittel |
JP2008505926A (ja) | 2004-07-09 | 2008-02-28 | グラクソ グループ リミテッド | 抗細菌剤 |
JP2008506695A (ja) | 2004-07-13 | 2008-03-06 | グラクソ グループ リミテッド | 抗細菌剤 |
JP2008507543A (ja) | 2004-07-22 | 2008-03-13 | グラクソ グループ リミテッド | 抗細菌剤 |
JP2008508359A (ja) | 2004-08-02 | 2008-03-21 | グラクソ グループ リミテッド | 抗菌剤 |
US20070161627A1 (en) | 2004-08-09 | 2007-07-12 | Miller William H | Antibacterial agents |
DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
CA2580621A1 (en) | 2004-09-24 | 2006-03-30 | Actelion Pharmaceuticals Ltd | New bicyclic antibiotics |
ES2343127T3 (es) | 2004-10-05 | 2010-07-23 | Actelion Pharmaceuticals Ltd. | Nuevos antibioticos de piperidina. |
JP5314244B2 (ja) | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | 新規な含窒素複素環化合物およびその塩 |
EP1846411A4 (de) | 2005-01-25 | 2010-08-04 | Glaxo Group Ltd | Antibakterielle wirkstoffe |
US7709472B2 (en) | 2005-01-25 | 2010-05-04 | Glaxo Group Limited | Antibacterial agents |
EP1846416A4 (de) | 2005-01-25 | 2009-07-01 | Glaxo Group Ltd | Antibakterielle wirkstoffe |
EP1846418A4 (de) | 2005-01-25 | 2009-12-23 | Glaxo Group Ltd | Antibakterielle wirkstoffe |
WO2006081264A1 (en) | 2005-01-25 | 2006-08-03 | Glaxo Group Limited | Antibacterial agents |
WO2006099884A1 (en) | 2005-03-24 | 2006-09-28 | Actelion Percurex Ag | Beta-aminoalcohol antibiotics |
AU2006230364B2 (en) | 2005-03-31 | 2012-09-13 | Janssen Pharmaceutica N.V. | Bicyclic pyrazole compounds as antibacterial agents |
US20090131444A1 (en) | 2005-05-24 | 2009-05-21 | Astrazeneca Ab | Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
US7981886B2 (en) | 2005-05-25 | 2011-07-19 | Actelion Pharmaceutical Ltd. | Antibiotics derivatives |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
EP2468743A1 (de) | 2005-06-24 | 2012-06-27 | Toyama Chemical Co., Ltd. | Bicyclischen Stickstoff enthaltende heterocyclische Verbindungen zur Verwendung als antibakterielle Mittel |
DK1954697T3 (da) | 2005-10-21 | 2010-06-14 | Glaxo Group Ltd | Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler |
EP1963324B1 (de) | 2005-12-22 | 2010-04-21 | Glaxo Group Limited | Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel |
GB0608263D0 (en) | 2006-04-26 | 2006-06-07 | Glaxo Group Ltd | Compounds |
GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
GB0705672D0 (en) | 2007-03-23 | 2007-05-02 | Glaxo Group Ltd | Compounds |
-
2007
- 2007-03-29 WO PCT/EP2007/053056 patent/WO2007115947A1/en active Application Filing
- 2007-03-29 US US12/295,749 patent/US7709483B2/en not_active Expired - Fee Related
- 2007-03-29 DE DE602007009205T patent/DE602007009205D1/de active Active
- 2007-03-29 JP JP2009503546A patent/JP2009532423A/ja active Pending
- 2007-03-29 AT AT07727528T patent/ATE481406T1/de not_active IP Right Cessation
- 2007-03-29 EP EP07727528A patent/EP2001887B1/de active Active
- 2007-04-03 AR ARP070101417A patent/AR060287A1/es unknown
- 2007-04-04 TW TW096111925A patent/TW200815450A/zh unknown
- 2007-04-04 PE PE2007000411A patent/PE20080182A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200815450A (en) | 2008-04-01 |
AR060287A1 (es) | 2008-06-04 |
EP2001887A1 (de) | 2008-12-17 |
US7709483B2 (en) | 2010-05-04 |
PE20080182A1 (es) | 2008-05-01 |
EP2001887B1 (de) | 2010-09-15 |
DE602007009205D1 (de) | 2010-10-28 |
US20090062265A1 (en) | 2009-03-05 |
WO2007115947A1 (en) | 2007-10-18 |
JP2009532423A (ja) | 2009-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE481406T1 (de) | Pyrrolochinoxalinonderivate als antibakterielle mittel | |
ATE460417T1 (de) | Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten | |
DK1912647T3 (da) | Quinolinderivater som antibakterielle midler | |
DK2054030T3 (da) | Antimikrobielle midler | |
BRPI0720220A2 (pt) | Derivados de quinolinas antibacterianos | |
DK1901743T3 (da) | Quinolinderivater som antibakterielle midler | |
ATE443753T1 (de) | Nuancierungsmittel | |
DK1912648T3 (da) | Quinolinderivater som antibakterielle midler | |
DK2034997T3 (da) | Antibakterielle sammensætninger | |
ATE475662T1 (de) | Dihydropyrazolopyrimidinonderivate | |
ATE483711T1 (de) | Spiroindolinonderivate | |
ATE469905T1 (de) | Pyridopyrimidinonderivate | |
ATE512135T1 (de) | Spiroindolinonderivate | |
DK2035394T3 (da) | 2-pyrazincarboxamidderivater | |
DE602006010508D1 (de) | Substituierte triazolderivate als oxytocinantagonisten | |
ATE451356T1 (de) | Substituierte arylsulfonamide als antivirale mittel | |
DK2086968T3 (da) | 5-hydroxymethyl-oxazolidin-2-on-derivater | |
DE602007006553D1 (de) | Antibakterielle chinolinderivate | |
DK1912649T3 (da) | Quinolinderivater som antibakterielle midler | |
DK2099759T3 (da) | Antibakterielle chinolinderivater | |
DK1898914T3 (da) | Quinolinderivater som antibakterielle midler | |
DK2099760T3 (da) | Antibakterielle quinolinderivater | |
DE602007006231D1 (de) | Antibakterielle chinolinderivate | |
BRPI0712951A2 (pt) | Unidade de aplicação | |
DE602007010182D1 (de) | Antibakterielle chinolinderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |